Therefore, activating FXR can not only directly affect the differentiation and function of intestinal macrophages and reduce inflammatory factors, but also regulate the recruitment of intestinal macrophages, inhibit the activation and recruitment of intestinal macrophages, and thereby suppress the progression of inflammatory bowel disease (5). Here, NR1H4 is linked to inflammatory bowel disease.